临床试验 RSS 源
Feeder 用户关注最多的 临床试验 RSS 源，包括 ClinicalTrials.gov: Other terms: FAK | Funded by Industry | First posted in the last 14 days、ClinicalTrials.gov: Other terms: KRAS | Funded by Industry | First posted in the last 14 days 和 ClinicalTrials.gov: Other terms: CEA | Funded by Industry | First posted in the last 14 days。复制 RSS 源 URL，或在 Feeder 中免费关注。
相关主题
健康 RSS 源 医学研究 RSS 源 心理健康 RSS 源 心理学 RSS 源 公共卫生 RSS 源 制药 RSS 源 肿瘤学 RSS 源
建议修改ClinicalTrials.gov: Other terms: FAK | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: FAK | Funded by Industry | First posted in the last 14 days
ClinicalTrials.gov: Other terms: KRAS | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: KRAS | Funded by Industry | First posted in the last 14 days
ClinicalTrials.gov: Other terms: CEA | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: CEA | Funded by Industry | First posted in the last 14 days
New and updated CTIS clinical trials of the last 7 days
Feed highlighting the new and updated clinical trials published on CTIS of the past 7 days based on the selected search criteria
New and updated CTIS clinical trials of the last 7 days
Feed highlighting the new and updated clinical trials published on CTIS of the past 7 days based on the selected search criteria
New and updated CTIS clinical trials of the last 7 days
Feed highlighting the new and updated clinical trials published on CTIS of the past 7 days based on the selected search criteria
ClinicalTrials.gov: Antibody-mediated Rejection OR cAMR OR chronic AMR | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Antibody-mediated Rejection OR cAMR OR chronic AMR | Last update posted in the last 14 days
ClinicalTrials.gov: Epidermolysis Bullosa | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Epidermolysis Bullosa | Last update posted in the last 14 days
ClinicalTrials.gov: Acromegaly | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Acromegaly | Last update posted in the last 14 days
ClinicalTrials.gov: Obesity | Phase: Early Phase 1, 1, 2, 3, 4 | Funded by Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Obesity | Phase: Early Phase 1, 1, 2, 3, 4 | Funded by Industry | Last update posted in the last 14 days
ClinicalTrials.gov: "cervical cancer" | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: "cervical cancer" | Last update posted in the last 14 days
ClinicalTrials.gov: Systemic Lupus Erythematosus | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Systemic Lupus Erythematosus | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
ClinicalTrials.gov: Lupus Nephritis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Lupus Nephritis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
ClinicalTrials.gov: Systemic Sclerosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Systemic Sclerosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
ClinicalTrials.gov: Sjogren's Syndrome | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Sjogren's Syndrome | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
ClinicalTrials.gov: Multiple Sclerosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Multiple Sclerosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
ClinicalTrials.gov: Autoimmune Diseases | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Autoimmune Diseases | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
ClinicalTrials.gov: Amyloidosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Amyloidosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Statistics in Medicine
Table of Contents for Statistics in Medicine. List of articles from both the latest and EarlyView issues.
ClinicalTrials.gov: TAK228 | Studies updated in the last 14 days
Studies found on ClinicalTrials.gov by a search of: TAK228 | Last update posted in the last 14 days
Business Wire - News by Company: Incyte Corporation
Business Wire - The global leader in news distribution
Cancer Currents: An NCI Cancer Research Blog
<p>A blog featuring news and research updates from the National Cancer Institute.</p>
Drug Discovery and Development
Strategies & Technologies Driving Drug Discovery to Market
Wiley: Pharmaceutical Statistics: Table of Contents
Table of Contents for Pharmaceutical Statistics. List of articles from both the latest and EarlyView issues.
ClinicalTrials.gov: cetrelimab | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: cetrelimab | Last update posted in the last 14 days
Avalo Therapeutics, Inc. (AVTX) News
The latest news released by Avalo Therapeutics, Inc. (AVTX)
ClinicalTrials.gov: toripalimab | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: toripalimab | Last update posted in the last 14 days
ClinicalTrials.gov: tislelizumab | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: tislelizumab | First posted in the last 14 days
ClinicalTrials.gov: Other terms: NCT06087835 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: NCT06087835 | Last update posted in the last 14 days
Nature Reviews Cardiology
Nature Reviews Cardiology is a peer-reviewed journal for cardiologists and affiliated health-care professionals. The journal delivers timely interpretations of key scientific developments in cardiology and related areas of study. Nature Reviews Cardiology is published monthly in print and online, and includes commissioned news, commentary and opinion pieces, and comprehensive reviews. Articles are subject to rigorous peer-review and/or review by in-house editors. Topics covered include acute coronary syndromes, arrhythmias, angina, cardiomyopathy, concomitant disease, congenital conditions, coronary artery disease, heart failure, hypertension, imaging and other investigations, infection, interventional cardiology, pathology, stroke, surgery, thrombosis, transplantation, valvular disease and vascular disease, as well as general therapies, disease markers, genetics and public health.
ClinicalTrials.gov: enfortumab | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: enfortumab | First posted in the last 14 days
ClinicalTrials.gov: enfortumab | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: enfortumab | Last update posted in the last 14 days
ClinicalTrials.gov: SKB410 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: SKB410 | Last update posted in the last 14 days
ClinicalTrials.gov: CRB-701 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: CRB-701 | Last update posted in the last 14 days